Cormedix Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cormedix Inc. on May 15, 2014, covering events occurring between May 9, 2014, and May 13, 2014. The filing primarily addresses changes in corporate governance and executive compensation arrangements.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document references an upcoming earnings call to review financial results for the first quarter ended March 31, 2014, but does not disclose those figures within this report.
Material Changes
- Board Resignation: Gary Gelbfish, M.D., resigned as a member of the Board of Directors effective May 12, 2014. The resignation was not related to any disagreement with the company regarding operations, policies, or practices.
- Executive Employment Agreement: The company entered into an employment agreement with Chief Executive Officer Randy D. Milby, effective March 31, 2014, and expiring March 31, 2016.
Guidance, Outlook, and Management Commentary
The company announced an earnings call scheduled for May 13, 2014, to review financial results for the quarter ended March 31, 2014. No specific financial guidance or forward-looking projections were included in this filing.
Executive Compensation Details
The new agreement with CEO Randy Milby includes the following terms:
- Base Salary: $300,000 annually, with up to 50% payable in unregistered common stock at the CEO's discretion.
- Bonus: Eligible for an annual target bonus up to 100% of base salary, based on company and personal objectives. Up to 50% of the bonus value may be paid in equity.
- Board Election: The company must use best efforts to have Mr. Milby elected to the Board of Directors and include him in the management slate for every stockholders' meeting during the agreement term. He will not receive additional compensation for board service.
- Termination Provisions:
- For Cause/Resignation without Good Reason: Entitled only to accrued compensation; restricted stock and unvested options are forfeited.
- Without Cause/Good Reason: Entitled to 12 months of base salary and benefits; all restricted stock and unvested options accelerate and vest immediately.
- Change of Control: All restricted stock and unvested options accelerate and vest immediately.
Investor Verification Checklist
- Verify the financial results for the first quarter ended March 31, 2014, via the press release filed as Exhibit 99.1 or the earnings call transcript.
- Confirm the current composition of the Board of Directors following Dr. Gelbfish's resignation.
- Review the specific performance objectives set by the Board for Mr. Milby's annual bonus calculation.
- Monitor the status of Mr. Milby's election to the Board of Directors at the next stockholders' meeting.